Expert scientist and drug development leader to scale high-impact, AI-enabled quantitative systems pharmacology team to accelerate medicines to patients
“Britta’s appointment reflects our continued investment in delivering scientific excellence and client impact,” said Piet van der Graaf, Senior Vice President and Head of QSP at Certara. “She brings a unique combination of scientific expertise, industry leadership, and firsthand understanding of the client experience. As we continue to build the largest and most experienced QSP team in the industry, Britta will play a critical role in democratizing AI-enabled model-informed evidence generation for decision making.”
“I am excited to join Certara at such a pivotal time for the industry,” said Dr. Wagenhuber. “There is tremendous opportunity to scale AI-enabled, mechanistic modeling approaches to improve decision-making and bring innovative medicines to patients faster. I look forward to working with Certara’s world-class QSP team and partnering with clients to increase confidence in development decisions and unlock the full value of quantitative systems pharmacology.”
Certara（サターラ）について
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. 製薬、教育機関、規制当局のお客様 2,600人以上、70ヵ国にてサターラの技術やサービスが活用されています。Learn more at certara.com
サターラの問い合わせ先：
Sheila Rocchio
[email protected]
報道機関の皆様：
赤津笑美 (emi.akatsu@certara.com)
[email protected]
